Adamis Pharmaceuticals Corp

NASDAQ:ADMP   12:58:58 AM EDT
0.19
0.00 (-2.52%)
: $0.18 0.00 (-1.99%)
Earnings Announcements

Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results, Provides Corporate Update

Published: 11/14/2022 21:59 GMT
Adamis Pharmaceuticals Corp (ADMP) - Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Adamis Pharmaceuticals Corp - Qtrly Loss per Share $0.03.
Adamis Pharmaceuticals Corp - Qtrly Total Net Revenue $1.5 Million Versus $760,000.
Adamis Pharmaceuticals Corp- Cash and Cash Equivalents As of September 30, 2022 Were Approximately $2.4 Million.